Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
<h4>Aims</h4>Type 1 diabetes (T1D) is characterized by autoimmune depletion of insulin-producing pancreatic beta cells. We showed previously that deletion of the 12/15-lipoxygenase enzyme (12/15-LO, Alox15 gene) in NOD mice leads to nearly 100 percent protection from T1D. In this study,...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f42c924931446b8bba73f20a5d64368 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1f42c924931446b8bba73f20a5d64368 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1f42c924931446b8bba73f20a5d643682021-11-18T07:56:35ZDeletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.1932-620310.1371/journal.pone.0056763https://doaj.org/article/1f42c924931446b8bba73f20a5d643682013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23437231/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Aims</h4>Type 1 diabetes (T1D) is characterized by autoimmune depletion of insulin-producing pancreatic beta cells. We showed previously that deletion of the 12/15-lipoxygenase enzyme (12/15-LO, Alox15 gene) in NOD mice leads to nearly 100 percent protection from T1D. In this study, we test the hypothesis that cytokines involved in the IL-12/12/15-LO axis affect both macrophage and islet function, which contributes to the development of T1D.<h4>Methods</h4>12/15-LO expression was clarified in immune cells by qRT-PCR, and timing of expression was tested in islets using qRT-PCR and Western blotting. Expression of key proinflammatory cytokines and pancreatic transcription factors was studied in NOD and NOD-Alox15(null) macrophages and islets using qRT-PCR. The two mouse strains were also assessed for the ability of splenocytes to transfer diabetes in an adoptive transfer model, and beta cell mass.<h4>Results</h4>12/15-LO is expressed in macrophages, but not B and T cells of NOD mice. In macrophages, 12/15-LO deletion leads to decreased proinflammatory cytokine mRNA and protein levels. Furthermore, splenocytes from NOD-Alox15(null) mice are unable to transfer diabetes in an adoptive transfer model. In islets, expression of 12/15-LO in NOD mice peaks at a crucial time during insulitis development. The absence of 12/15-LO results in maintenance of islet health with respect to measurements of islet-specific transcription factors, markers of islet health, proinflammatory cytokines, and beta cell mass.<h4>Conclusions</h4>These results suggest that 12/15-LO affects islet and macrophage function, causing inflammation, and leading to autoimmunity and reduced beta cell mass.Shamina M Green-MitchellSarah A TerseyBanumathi K ColeKaiwen MaNorine S KuhnTina Duong CunninghamNelly A MaybeeSwarup K ChakrabartiMarcia McDuffieDavid A Taylor-FishwickRaghavendra G MirmiraJerry L NadlerMargaret A MorrisPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 2, p e56763 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shamina M Green-Mitchell Sarah A Tersey Banumathi K Cole Kaiwen Ma Norine S Kuhn Tina Duong Cunningham Nelly A Maybee Swarup K Chakrabarti Marcia McDuffie David A Taylor-Fishwick Raghavendra G Mirmira Jerry L Nadler Margaret A Morris Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. |
description |
<h4>Aims</h4>Type 1 diabetes (T1D) is characterized by autoimmune depletion of insulin-producing pancreatic beta cells. We showed previously that deletion of the 12/15-lipoxygenase enzyme (12/15-LO, Alox15 gene) in NOD mice leads to nearly 100 percent protection from T1D. In this study, we test the hypothesis that cytokines involved in the IL-12/12/15-LO axis affect both macrophage and islet function, which contributes to the development of T1D.<h4>Methods</h4>12/15-LO expression was clarified in immune cells by qRT-PCR, and timing of expression was tested in islets using qRT-PCR and Western blotting. Expression of key proinflammatory cytokines and pancreatic transcription factors was studied in NOD and NOD-Alox15(null) macrophages and islets using qRT-PCR. The two mouse strains were also assessed for the ability of splenocytes to transfer diabetes in an adoptive transfer model, and beta cell mass.<h4>Results</h4>12/15-LO is expressed in macrophages, but not B and T cells of NOD mice. In macrophages, 12/15-LO deletion leads to decreased proinflammatory cytokine mRNA and protein levels. Furthermore, splenocytes from NOD-Alox15(null) mice are unable to transfer diabetes in an adoptive transfer model. In islets, expression of 12/15-LO in NOD mice peaks at a crucial time during insulitis development. The absence of 12/15-LO results in maintenance of islet health with respect to measurements of islet-specific transcription factors, markers of islet health, proinflammatory cytokines, and beta cell mass.<h4>Conclusions</h4>These results suggest that 12/15-LO affects islet and macrophage function, causing inflammation, and leading to autoimmunity and reduced beta cell mass. |
format |
article |
author |
Shamina M Green-Mitchell Sarah A Tersey Banumathi K Cole Kaiwen Ma Norine S Kuhn Tina Duong Cunningham Nelly A Maybee Swarup K Chakrabarti Marcia McDuffie David A Taylor-Fishwick Raghavendra G Mirmira Jerry L Nadler Margaret A Morris |
author_facet |
Shamina M Green-Mitchell Sarah A Tersey Banumathi K Cole Kaiwen Ma Norine S Kuhn Tina Duong Cunningham Nelly A Maybee Swarup K Chakrabarti Marcia McDuffie David A Taylor-Fishwick Raghavendra G Mirmira Jerry L Nadler Margaret A Morris |
author_sort |
Shamina M Green-Mitchell |
title |
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. |
title_short |
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. |
title_full |
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. |
title_fullStr |
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. |
title_full_unstemmed |
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. |
title_sort |
deletion of 12/15-lipoxygenase alters macrophage and islet function in nod-alox15(null) mice, leading to protection against type 1 diabetes development. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/1f42c924931446b8bba73f20a5d64368 |
work_keys_str_mv |
AT shaminamgreenmitchell deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT sarahatersey deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT banumathikcole deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT kaiwenma deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT norineskuhn deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT tinaduongcunningham deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT nellyamaybee deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT swarupkchakrabarti deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT marciamcduffie deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT davidataylorfishwick deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT raghavendragmirmira deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT jerrylnadler deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment AT margaretamorris deletionof1215lipoxygenasealtersmacrophageandisletfunctioninnodalox15nullmiceleadingtoprotectionagainsttype1diabetesdevelopment |
_version_ |
1718422716467380224 |